Publications - Page 4 sur 43 - RespiFIL - Filière de santé des maladies respiratoires rares

Voici les publications scientifiques relatives aux maladies respiratoires rares auxquelles les membres de la filière ont contribué, classées par groupes de pathologies (depuis juillet 2021).

Hypertension pulmonaire (HTP)
Thirty years of surgical management of pediatric pulmonary hypertension :mid-term outcomes following reverse Potts shunt and transplantation.

Valdeolmillos E, Le Pavec J, Audié M, Savale L, Jais X, Montani D, Sitbon O, Feuillet S, Mercier O, Petit J, Humbert M, Fadel E, Belli E, Hascoët S.

J Thorac Cardiovasc Surg. 2023 Dec 3:S0022-5223(23)01121-2.
Hypertension pulmonaire (HTP)
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension.

Welch CL, Aldred MA, Balachandar S, Dooijes D, Eichstaedt CA, Gräf S, Houweling AC, Machado RD, Pandya D, Prapa M, Shaukat M, Southgate L, Tenorio-Castano J; ClinGen PH VCEP; Chung WK; International Consortium for Genetic Studies in Pulmonary Arterial Hypertension (PAH-ICON) at the Pulmonary Vascular Research Institute (PVRI).

Genet Med. 2023 Nov;25(11):100925.
Hypertension pulmonaire (HTP)
KCNK3 channel is important for the ventilatory response to hypoxia in rats.

Yegen CH, Lambert M, Beurnier A, Montani D, Humbert M, Planès C, Boncoeur E, Voituron N, Antigny F.

Respir Physiol Neurobiol. 2023 Dec;318:104164.
Hypertension pulmonaire (HTP)
Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension.

Mismetti V, Delavenne X, Montani D, Bezzeghoud S, Delezay O, Hodin S, Launay D, Marchand-Adam S, Nunes H, Ollier E, Reynaud-Gaubert M, Pastre J, Traclet J, Quetant S, Zeghmar S, Bertoletti L, Cottin V.

Respir Res. 2023 Nov 7;24(1):273.
Hypertension pulmonaire (HTP)
Updated Hemodynamic Definition and Classification of Pulmonary Hypertension.

Lechartier B, Kularatne M, Jaïs X, Humbert M, Montani D.

Semin Respir Crit Care Med. 2023 Dec;44(6):721-727.
Hypertension pulmonaire (HTP)
Pulmonary hypertension associated with diazoxide: the SUR1 paradox.

Montani D, Antigny F, Jutant EM, Chaumais MC, Le Ribeuz H, Grynblat J, Khouri C, Humbert M.

ERJ Open Res. 2023 Nov 13;9(6):00350-2023.
Pneumopathies interstitielles diffuses (PID)
The association between air pollution and the severity at diagnosis and progression of systemic sclerosis-associated interstitial lung disease: results from the retrospective ScleroPol study.

Roeser A, Sese L, Chassagnon G, Chaigne B, Dunogue B, Tran Ba S, Jebri S, Brillet PY, Revel MP, Aubourg F, Dhote R, Caux F, Annesi-Maesano I, Mouthon L, Nunes H, Uzunhan Y.

Respir Res. 2023 Jun 8;24(1):151.
Pneumopathies interstitielles diffuses (PID)
How does the MESA Lung Study sharpen blurry edges in interstitial lung abnormalities?

Brillet PY, Tran Ba S, Nunes H.

Eur Respir J. 2023 Jun 8;61(6):2300397.
Anomalies du contrôle respiratoire
Effect of Facemask in Congenital Central Hypoventilation Syndrome

Dudoignon B, Patout M, Couque N, Delclaux C, Bokov P.

Respiration. 2023 Dec 1:22-25.
Hypertension pulmonaire (HTP)
Conseil génétique et dépistage de l’hypertension artérielle pulmonaire – consensus du Consortium international pour les études génétiques dans l’HTAP – version française

D. Montani, C.A. Eichstaedt, C. Belge, W.K. Chung, S. Gräf, E. Grünig, M. Humbert, R. Quarck, J.A. Tenorio-Castano, F. Soubrier, R.C. Trembath, N.W. Morrell, for the PAH-ICON associated with the PVRI

Revue des Maladies Respiratoires

FILTRER :

Par mot clé

Par maladies

Réinitialiser les filtres

Thirty years of surgical management of pediatric pulmonary hypertension :mid-term outcomes following reverse Potts shunt and transplantation.

Defining the clinical validity of genes reported to cause pulmonary arterial hypertension.

KCNK3 channel is important for the ventilatory response to hypoxia in rats.

Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension.

Updated Hemodynamic Definition and Classification of Pulmonary Hypertension.

Pulmonary hypertension associated with diazoxide: the SUR1 paradox.

The association between air pollution and the severity at diagnosis and progression of systemic sclerosis-associated interstitial lung disease: results from the retrospective ScleroPol study.

How does the MESA Lung Study sharpen blurry edges in interstitial lung abnormalities?

Effect of Facemask in Congenital Central Hypoventilation Syndrome

Conseil génétique et dépistage de l’hypertension artérielle pulmonaire – consensus du Consortium international pour les études génétiques dans l’HTAP – version française